MIF and neoplasm: Studies showing that human tumor cells themselves are able to activate MAPK-mediated IL8 and VEGF expression by binding of MIF to its main receptor CD747,12,27,28,35,53 were confirmed within this study in human CRC cells (Fig. 5).